Nanomedicines for Brain Targeting: A Patent Review

Publisher： Bentham Science Publishers

E-ISSN： 1877-9131|1|2|149-161

ISSN： 1877-9123

Source： Recent Patents on Nanomedicine, Vol.1, Iss.2, 2011-01, pp. : 149-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges

By  

Current Clinical Pharmacology, Vol. 13, Iss. 2, 2018-05 ,pp. : 110-119

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting survivin in cancer: patent review

By Kanwar Jagat R   Kamalapuram Sishir K   Kanwar Rupinder K  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1723-1737

Informa Healthcare

Access to resources Recommend Favorite

Drug Targeting to the Brain - A Review

By  

Current Nanoscience, Vol. 7, Iss. 1, 2011-02 ,pp. : 21-36

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomedicines for Receptor-Mediated Tumor Targeting

By  

Recent Patents on Nanomedicine, Vol. 1, Iss. 2, 2011-12 ,pp. : 138-148

Bentham Science Publishers

Access to resources Recommend Favorite

Patented nanomedicines for the treatment of brain tumors

By Caruso Gerardo   Raudino Giuseppe   Caffo Maria  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. : 745-754

Future Science

Access to resources Recommend Favorite